TABLE 1—
HIV Positivity by Demographic and HIV Testing-Related Characteristics for Tests Conducted at Correctional Facilities: 16 Health Departments, United States, 2007
| HIV-Positive |
||||
| Characteristica | Total Tests, No. (%) | Total, No. (%) | Previously Identified, No. (%) | Newly Identified, No. (%) |
| Total | 106 122 (100.0) | 1006 (0.9) | 251 (0.2) | 755 (0.7) |
| Gender | ||||
| Male | 80 278 (75.7) | 640 (0.8) | 177 (0.2) | 463 (0.6) |
| Female | 25 144 (23.7) | 347 (1.4) | 67 (0.3) | 280 (1.1) |
| Age group, y | ||||
| 13–19 | 11 448 (10.8) | 26 (0.2) | 5 (0.0) | 21 (0.2) |
| 20–29 | 41 001 (38.6) | 252 (0.6) | 53 (0.1) | 199 (0.5) |
| 30–39 | 25 784 (24.3) | 314 (1.2) | 82 (0.3) | 232 (0.9) |
| 40–49 | 21 378 (20.1) | 308 (1.4) | 73 (0.3) | 235 (1.1) |
| 50–64 | 6511 (6.1) | 106 (1.6) | 38 (0.6) | 68 (1.0) |
| Race/ethnicity | ||||
| White | 32 856 (31.0) | 215 (0.7) | 55 (0.2) | 160 (0.5) |
| Black | 50 308 (47.4) | 634 (1.3) | 141 (0.3) | 493 (1.0) |
| Hispanic | 19 333 (18.2) | 142 (0.7) | 49 (0.2) | 93 (0.5) |
| Asian/Pacific Islander | 718 (0.7) | 2 (0.3) | 2 (0.3) | 0 |
| American Indian/Alaska Native | 636 (0.6) | 5 (0.8) | 1 (0.2) | 4 (0.6) |
| Other | 2271 (1.4) | 8 (0.3) | 3 (0.1) | 5 (0.2) |
| Region | ||||
| Northeast | 30 793 (29.0) | 180 (0.6) | 62 (0.2) | 118 (0.4) |
| Midwest | 2404 (2.3) | 11 (0.5) | 6 (0.3) | 5 (0.2) |
| South | 60 491 (57.0) | 743 (1.2) | 167 (0.3) | 576 (0.9) |
| West | 12 434 (11.7) | 72 (0.6) | 16 (0.1) | 56 (0.5) |
| Risk category | ||||
| MSM/IDU | 681 (0.6) | 29 (4.3) | 13 (1.9) | 16 (2.4) |
| MSM only | 2330 (2.2) | 129 (5.5) | 46 (2.0) | 83 (3.6) |
| IDU | 13 672 (12.9) | 141 (1.0) | 45 (0.3) | 96 (0.7) |
| High-risk heterosexual contactb | 47 452 (44.7) | 348 (0.7) | 72 (0.1) | 276 (0.6) |
| Low-risk heterosexual contactc | 23 074 (21.7) | 193 (0.8) | 38 (0.2) | 155 (0.7) |
| No acknowledged risk | 12 049 (11.4) | 92 (0.8) | 24 (0.2) | 68 (0.6) |
| Otherd | 2704 (2.6) | 42 (1.6) | 5 (0.2) | 37 (1.4) |
| Testing history | ||||
| Previously tested | 75 696 (71.3) | 753 (1.0) | 251 (0.3) | 502 (0.7) |
| First-time tested | 30 426 (28.7) | 253 (0.8) | NA | 253 (0.8) |
| Provision of test results and posttest counseling | ||||
| No | 9038 (8.5) | 137 (1.5) | 69 (0.8) | 68 (0.7) |
| Yes | 94 667 (89.2) | 851 (0.9) | 180 (0.2) | 671 (0.7) |
Note. IDU = injection drug user; MSM = men who have sex with men; NA = not applicable. Data from the following 16 health departments were included: CA (excluding San Francisco and Los Angeles), DE, DC, FL, GA, LA, MA, MI, NY (excluding New York City), OH, OR, PA (excluding Philadelphia), TX (excluding Houston), VA, San Francisco, and Los Angeles.
The number of records for each variable does not sum to the total number of records because of missing data. The number (%) of missing values for the selected variables were as follows: gender, 700 (0.7%); race/ethnicity, 812 (0.8%); risk category, 4160 (3.9%); and posttest counseling, 2417 (2.3%).
Person reporting heterosexual contact who also reported any of the following: sex with partner at risk, a diagnosis of a sexually transmitted disease, exchange of sex for drugs or money, noninjection drug use during sex, or a victim of sexual assault.
Person reporting heterosexual contact and no other risk factor.
Person reporting other risk factors (i.e., perinatal exposure, hemophilia, receipt of blood transfusion, or health care exposure).